Monday, October 16, 2023 12:35:56 PM
During the initial phase of commissioning a recovery rate of 86% for both Platinum (Pt) and Palladium (Pd) were consistently achieved. By the end of the commissioning phase recoveries of 94% for Pt and 98% for Pd were attained. The recovery rates reported previously were solely for the leaching process. The overall recovery results currently reported reflect the entirety of the process including all sections where potential precious metal losses occur, such as leaching, solid/liquid separation and the Merrill Crowe recovery.
“The team is very excited being able to replicate the results from the lab and pilot plant trials during the start up commissioning phase. These results were obtained using very low-grade materials which makes this even more exciting as low-grade material was the most challenging to obtain high recoveries in the lab environment. Everyone at Regenx is excited as we enter the next stage of the Company’s development as a fully commercial operation. The Company’s vision is to become a global solution for an ever increasing multi-billion dollar problem”, stated Greg Pendura, CEO.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM